J Gen Virol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online ahead of print on 7 May 2009 as doi:10.1099/vir.0.011700-0
Journal of General Virology 2009;90:1906.

A more recent version of this article appeared on August 1, 2009 J Gen Virol (2009), DOI 10.1099/vir.0.011700-0
© 2009 Society for General Microbiology

This Article
Right arrow Full Text (Papers in Press[PDF])
Right arrow All Versions of this Article:
vir.0.011700-0v1
90/8/1906    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chambers, R.
Right arrow Articles by Takimoto, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chambers, R.
Right arrow Articles by Takimoto, T.
Agricola
Right arrow Articles by Chambers, R.
Right arrow Articles by Takimoto, T.

Host specificity of the anti-interferon and anti-apoptosis activities of parainfluenza virus P/C gene products

Raychel Chambers and Toru Takimoto1

University of Rochester Medical Center

1 E-mail: toru_takimoto{at}urmc.rochester.edu

Human parainfluenza virus type 1 (hPIV1) and Sendai virus (SeV) are highly homologous in structure and sequence, while maintaining distinct host ranges. These viruses express accessory proteins from their P/C gene, which are known to have anti-innate activities. The accessory proteins expressed from the P/C genes are different between these viruses. In addition to the nested set of C proteins, SeV expresses V protein from edited P mRNA, which is not expressed by hPIV1. In this study, we evaluated the host specificity and role of P/C gene products in anti-IFN and anti-apoptosis activity by characterizing a recombinant SeV, rSeVhP, in which the SeV P/C gene was replaced with that of hPIV1. Unlike SeV, rSeVhP infection strongly activated IRF-3 and NF-{kappa}B, resulting in an increased level in IFN-β induction compared to SeV in murine cells. In contrast, activation of IRF-3 was not observed in rSeVhP-infected human A549 cells. rSeVhPSV, which expresses SeV V protein from an inserted gene in rSeVhP induced less IFN-β than rSeVhP, suggesting V contributes to suppression of IFN production in murine cells. Furthermore, rSeVhP induced apoptotic cell death in murine but not in A549 cells. These data indicate the functional difference of P/C gene products from SeV and hPIV1 in antagonizing IFN induction and apoptosis, which is likely to be one of the major factors for pathogenicity to specific hosts.

Received 9 March 2009; accepted 23 April 2009.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2009 by the Society for General Microbiology.